1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. LENSAR INC
LENSAR Inc
XNAS: LNSR
23,868
XNAS Volume

XNAS 13 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

LENSAR Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for LENSAR Inc share price target, revenues, EPS, net income and more

LENSAR Inc quarterly results: revenue, profit, and P&L – 13 quarter history

  • POSITIVE

    Quarterly Revenue LENSAR Inc Jun-2026 Quarterly Revenue is $16 Million which is growth of 18.4% YoY.

  • POSITIVE

    Quarterly Net Profit LENSAR Inc Jun-2026 Quarterly Net Profit is $4 Million which is growth of 300.4% YoY.

LENSAR Inc, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
16.513.41614.313.914.216.713.512.610.612.19.812
Cost Of Rev.
6.77.19.18.36.979.67.35.84.974.95.3
Gross Profit
9.86.46.9677.17.16.36.85.75.24.96.8
⌄
7.64.111.913.613.312.98.47.58.48.58.16.99.6
Operating Profit
2.12.2-4.9-7.6-6.3-5.8-1.3-1.2-1.6-2.9-3-2-2.9
-------------
Profit Before Tax
3.536.3-1.5-3.7-1.8-27.3-18.7-1.5-9-2.2-3.92.6-8.8
Tax
-------------
⌄
1.818.9-1.5-3.7-1.8-27.3-18.7-1.5-9-2.2-3.91.4-8.8
Diluted NI Avail to Com Stockholders Ann.
2.30-1.5-3.7-1.8-27.3-18.7-1.5-9-2.2-3.9-2.8-8.8
Basic EPS
0.11.6-0.1-0.3-0.2-2.3-1.6-0.1-0.8-0.2-0.40.1-0.8
Diluted EPS After ExtraOrdinary
0.1-1.3-0.4-0.6-0.5-0.5-0.1-0.1-0.1-0.2-0.2-0.5-0.3
Number Of Shares End
12.312.212.11211.911.811.611.611.511.411.211.110.8
Net Income Continuing Discontinued Operations
3.536.3-1.5-3.7-1.8-27.3-18.7-1.5-9-2.2-3.92.6-8.8
Normalized Income
2.810.1-3.9-6.6-5.3-4.9-0.5-0.4-0.7-1.9-1.90.1-0.9
Interest Income
-------------
Interest
-------------
Net Interest Income
-------------
EBIT
3.536.3-1.5-3.7-1.8-27.3-18.7-1.5-9.1-2.2-3.92.6-8.8
EBITDA
4.637.5-0.3-2.6-0.7-26.3-17.6-0.5-8.2-1.2-33.5-7.9
Reconciled Cost Of Rev.
5.86.18.17.46.16.28.86.55.24.36.34.34.7
Reconciled Depr.
1.11.11.21.21.11.11.110.90.90.90.90.9
Profit From Continuing Operations
3.536.3-1.5-3.7-1.8-27.3-18.7-1.5-9-2.2-3.92.6-8.8
Normalized EBITDA
2-30.6-7.1-10.2-9.51717.40.27-2.4-0.8-5.54
*All financials are in USD Million and price data in USD

LENSAR Inc competitor comparison and performance snapshot within industry

LENSAR Inc annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

  • POSITIVE

    Annual Revenue LENSAR Inc Dec-2025 Annual Revenue is $58 Million which is growth of 9.2% YoY.

  • NEGATIVE

    Annual Net Profit LENSAR Inc Dec-2025 Annual Net Profit is $-34 Million which is growth of -9.2% YoY.

LENSAR Inc, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19
18.2%
17.2%
 58.453.542.235.434.526.430.5
Cost Of Rev. Ann.
26.7%
20.5%
31.131.327.621.115.416.612.317.3
Gross Profit Ann.
10.7%
14%
29.127.125.921.12017.814.113.2
Operating Exp. Ann.
8.8%
9.7%
37.351.732.833.340.137.532.625.9
Operating Profit Ann.
-
-
-8.1-24.6-6.9-12.2-20.2-19.7-18.5-12.7
-
-
 -----1.3-2
Other Exp. Ann.
-
-
 -9.7-24.5-2.20.30.10.10.1
PBT Ann.
-
-
34.7-34.3-31.4-14.4-19.9-19.6-19.8-14.7
Tax Ann.
-
-
 -------
⌄
-
-
15.5-34.3-31.4-14.4-19.9-19.6-19.8-14.7
Diluted NI Avail to Com Stockholders Ann.
-
-
-2.8-34.3-31.4-14.4-19.9-19.6-19.8-14.7
EPS Ann.
-
-
 -2.9-2.7-1.3-2-2.1-4.3-1.4
Diluted EPS Ann.
-
-
 -2.9-2.7-1.3-2-2.1-4.3-1.4
Number Of Shares End
5.2%
2.1%
 12.111.611.210.49.610.910.6
Total Exp. Ann.
14.4%
13.1%
 8360.454.455.554.144.943.2
Net Income Continuing Discontinued Operations Ann.
-
-
34.7-34.3-31.4-14.4-19.9-19.6-19.8-14.7
Normalized Income Ann.
-
-
2.4-20.7-3.5-5.9-13.2-12.3-10.7-14.6
Interest Income Ann.
-
-
 -------
Interest Ann.
-
-
 ----1.32
EBITDA Ann.
-
-
39.2-29.8-27.5-10.9-16.5-16.3-15.9-8.8
Reconciled Cost Of Rev. Ann.
28.4%
20.3%
27.527.724.718.613.115.11114.7
Reconciled Depr. Ann.
9.8%
11.6%
4.64.53.93.53.42.82.63.9
Profit From Continuing Operations Ann.
-
-
34.7-34.3-31.4-14.4-19.9-19.6-19.8-14.7
Normalized EBITDA Ann.
-
-
-45.8-9.722.1-5.9-16.8-16.8-15.9-8.8
*All financials are in USD Million and price data in USD
Total Rev. Ann.
1Y CHG
9.2%
2Y CAGR
17.6%
3Y CAGR
18.2%
5Y CAGR
17.2%
Operating Exp. Ann.
1Y CHG
57.6%
2Y CAGR
24.6%
3Y CAGR
8.8%
5Y CAGR
9.7%

LENSAR Inc balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

  • NEGATIVE

    Total Shareholders Fund LENSAR Inc Dec-2025 Total Shareholders Fund is $-26 Million which is growth of -635.2% YoY.

  • POSITIVE

    Total Assets LENSAR Inc Dec-2025 Total Assets is $71 Million which is growth of 7.7% YoY.

LENSAR Inc, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19
8.6%
-2%
71.466.369.655.866.579.134.5
⌄
91.4%
52.3%
97.561.436.213.911.611.965.1
⌄
-
-
-264.933.44254.967.2-30.6
Total Capitalization Ann.
-
-
-264.933.44254.967.2-10.4
Tangible Assets Ann.
-
-
-31.2-1.322.429.94455.1-43.9
Working Capital Ann.
-34.7%
-34.1%
6.22734.822.336.149.99.4
Invested Capital Ann.
-
-
-264.933.44254.967.2-10.4
Tangible Book Value Ann.
-
-
-31.2-1.322.429.94455.1-43.9
Borrowings Ann.
-1.2%
-3.9%
2.72.62.32.83.33.320.5
Net Debt Ann.
-
-
------15.6
Share Issued Ann.
2.6%
1.9%
1211.711.311.11110.910.6
Number Of Shares End
5.2%
2.1%
12.111.611.210.49.610.910.6
*All financials are in USD Million and price data in USD
Total Assets Ann.
1Y CHG
7.7%
2Y CAGR
1.3%
3Y CAGR
8.6%
5Y CAGR
-2%
Total Current Liabilities Ann.
1Y CHG
170.7%
2Y CAGR
87.1%
3Y CAGR
52.7%
5Y CAGR
36.7%

LENSAR Inc ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

  • NEGATIVE

    Book Value Per Share LENSAR Inc Book Value Per Share is $-2 which is growth of -619.4% YoY.

  • NEUTRAL

    ROE LENSAR Inc ROE is 0% which is growth of 0% YoY.

LENSAR Inc, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19
RoA Ann. %
-
-
--46.22%-22.93%-32.56%-26.93%-34.80%-42.44%
ROE Ann. %
-
-
--164.03%-38.14%-41.12%-32.11%-107.89%-
ROIC %
-
-
--116.5-10.5-5.5-6.6-9.6-
OPM Ann. %
-
-
-42.06%-12.97%-29.00%-57.06%-57.03%-70.13%-41.65%
Inventory Turnover Ratio Ann.
-
-
-21.51.71.71.12.2
Asset Turnover Ann. %
-
-
-0.80.70.60.50.50.9
Working Capital Turnover Ann.
80.4%
79.8%
9.421.21.610.53.3
Quick Ratio Ann.
-
-
-1.92.41.84.25.11.1
Current Ratio Ann.
-
-
-2.8435.16.92.2
Interest Coverage Ratio Ann.
-
-
------13.8-6.3
LT Debt To Equity Ann.
-
-
-0.40.10.10.10.1-
*All financials are in USD Million and price data in USD

LENSAR Inc cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

  • NEGATIVE

    Cash From Operating Activity LENSAR Inc Dec-2025 Cash From Operating Activity is $-15 Million which is growth of -551.9% YoY.

  • POSITIVE

    Net Cash Flow LENSAR Inc Dec-2025 Net Cash Flow is $-3 Million which is growth of 24.5% YoY.

LENSAR Inc, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19
-
-
-14.8-2.3-9.7-14.9-9-13.8-12.6
-
-
1.3-2.2-4.2-0.1-0.4-0.3-2.1
-
-27.1%
10.30.119.8-20.45016
Cash Plus Cash Eqv. End Of Year Ann.
-4%
-20.4%
1316.320.614.731.640.64.7
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-
-3.3-4.46-17-935.91.3
Cash Plus Cash Eqv. Begin Of Year Ann.
-19.8%
28.2%
16.320.614.731.640.64.73.4
Income Tax Paid Supplemental Data Ann.
-
-
0000--
Interest Paid Supplemental Data Ann.
-
-
---0.50.5
Capex Ann.
-
-
-0.1-0.2-0.2-0.1-0.4-0.4-2.1
Issuance Of Capital Stock Ann.
-
-69.8%
0.10.113.9-39.53.8
Issuance Of Debt Ann.
-
-
----12.413.2
Repayment Of Debt Ann.
-
-
-------
Repurchase Of Capital Stock Ann.
-
-
-------
Free Cash Flow Ann.
-
-
-14.9-2.4-9.9-15-9.3-14.2-14.7
*All financials are in USD Million and price data in USD
Cash from Financing Act. Ann.
1Y CHG
10200%
2Y CAGR
-27.9%
5Y CAGR
-27.1%